Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Douwe Postmus

Showing results (1-10 of 78) with videos related to

Pageof 8
Sort By:
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 10, 2019
From Individual to Population Preferences: Comparison of Discrete Choice and Dirichlet Models for Treatment Benefit-Risk TradeoffsTommi Tervonen, Francesco Pignatti, Douwe Postmus
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2024
Multidimensional Thresholding for Individual-Level Preference ElicitationSebastian Heidenreich, Douwe Postmus, Tommi Tervonen
Biomed Research International|October 24, 2015
Using multicriteria decision analysis to support research priority setting in biomedical translational research projectsGimon de Graaf, Douwe Postmus, Erik Buskens
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 12, 2016
Tools and Techniques - Statistical. Estimating cumulative incidences in the presence of right-censoring and competing risks: an introduction with illustrations from the COACH studyDouwe Postmus, Biniyam G Demissei, Hans L Hillege
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Probability elicitation to inform early health economic evaluations of new medical technologies: a case study in heart failure disease managementQi Cao, Douwe Postmus, Hans L Hillege, et al.
Cost Effectiveness and Resource Allocation : C/E|June 28, 2018
The early economic evaluation of novel biomarkers to accelerate their translation into clinical applicationsGimon de Graaf, Douwe Postmus, Jan Westerink, et al.
Statistics in Medicine|September 27, 2022
A simulated maximum likelihood procedure for analyzing imprecise trade-off thresholds between the benefits and harms of medicinesDouwe Postmus, Francesco Pignatti, Hans L Hillege, et al.
Frontiers in Public Health|December 18, 2025
Impact of the COVID-19 pandemic waves on adults with moderate-to-severe atopic dermatitis in the Dutch general population: a population-based longitudinal cohort studyRui Chen, Laura Loman, Douwe Postmus, et al.
Journal of Clinical Epidemiology|July 6, 2015
Design of stepwise screening for prediabetes and type 2 diabetes based on costs and cases detectedGimon de Graaf, Douwe Postmus, Stephan J L Bakker, et al.
Statistics in Medicine|January 27, 2011
A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysisTommi Tervonen, Gert van Valkenhoef, Erik Buskens, et al.
Pageof 8

Showing results (1-10 of 78) with videos related to

Sort By:
Pageof 8
Medical Decision Making : an International Journal of the Society for Medical Decision Making|September 10, 2019
From Individual to Population Preferences: Comparison of Discrete Choice and Dirichlet Models for Treatment Benefit-Risk TradeoffsTommi Tervonen, Francesco Pignatti, Douwe Postmus
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 1, 2024
Multidimensional Thresholding for Individual-Level Preference ElicitationSebastian Heidenreich, Douwe Postmus, Tommi Tervonen
Biomed Research International|October 24, 2015
Using multicriteria decision analysis to support research priority setting in biomedical translational research projectsGimon de Graaf, Douwe Postmus, Erik Buskens
Eurointervention : Journal of Europcr in Collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology|February 12, 2016
Tools and Techniques - Statistical. Estimating cumulative incidences in the presence of right-censoring and competing risks: an introduction with illustrations from the COACH studyDouwe Postmus, Biniyam G Demissei, Hans L Hillege
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Probability elicitation to inform early health economic evaluations of new medical technologies: a case study in heart failure disease managementQi Cao, Douwe Postmus, Hans L Hillege, et al.
Cost Effectiveness and Resource Allocation : C/E|June 28, 2018
The early economic evaluation of novel biomarkers to accelerate their translation into clinical applicationsGimon de Graaf, Douwe Postmus, Jan Westerink, et al.
Statistics in Medicine|September 27, 2022
A simulated maximum likelihood procedure for analyzing imprecise trade-off thresholds between the benefits and harms of medicinesDouwe Postmus, Francesco Pignatti, Hans L Hillege, et al.
Frontiers in Public Health|December 18, 2025
Impact of the COVID-19 pandemic waves on adults with moderate-to-severe atopic dermatitis in the Dutch general population: a population-based longitudinal cohort studyRui Chen, Laura Loman, Douwe Postmus, et al.
Journal of Clinical Epidemiology|July 6, 2015
Design of stepwise screening for prediabetes and type 2 diabetes based on costs and cases detectedGimon de Graaf, Douwe Postmus, Stephan J L Bakker, et al.
Statistics in Medicine|January 27, 2011
A stochastic multicriteria model for evidence-based decision making in drug benefit-risk analysisTommi Tervonen, Gert van Valkenhoef, Erik Buskens, et al.
Pageof 8